IT1399334B1 - Test elisa indiretto per l'identificazione nel siero e in altri fluidi umani di anticorpi contro il virus sv40 mediante l'uso di peptidi sintetici specifici della sua regione precoce, codificante per l'oncoproteina antigene t grande - Google Patents
Test elisa indiretto per l'identificazione nel siero e in altri fluidi umani di anticorpi contro il virus sv40 mediante l'uso di peptidi sintetici specifici della sua regione precoce, codificante per l'oncoproteina antigene t grandeInfo
- Publication number
- IT1399334B1 IT1399334B1 ITFE2009A000010A ITFE20090010A IT1399334B1 IT 1399334 B1 IT1399334 B1 IT 1399334B1 IT FE2009A000010 A ITFE2009A000010 A IT FE2009A000010A IT FE20090010 A ITFE20090010 A IT FE20090010A IT 1399334 B1 IT1399334 B1 IT 1399334B1
- Authority
- IT
- Italy
- Prior art keywords
- anticorpi
- precoce
- codifying
- oncoprotein
- tea
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/22011—Polyomaviridae, e.g. polyoma, SV40, JC
- C12N2710/22022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
- G01N2333/01—DNA viruses
- G01N2333/025—Papovaviridae, e.g. papillomavirus, polyomavirus, SV40, BK virus, JC virus
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Virology (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Hematology (AREA)
- Microbiology (AREA)
- Urology & Nephrology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Cell Biology (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Tropical Medicine & Parasitology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Peptides Or Proteins (AREA)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ITFE2009A000010A IT1399334B1 (it) | 2009-09-09 | 2009-09-09 | Test elisa indiretto per l'identificazione nel siero e in altri fluidi umani di anticorpi contro il virus sv40 mediante l'uso di peptidi sintetici specifici della sua regione precoce, codificante per l'oncoproteina antigene t grande |
PCT/IB2010/054064 WO2011030300A1 (en) | 2009-09-09 | 2010-09-09 | Synthetic peptides from the sv40 t-antigen for use in an indirect elisa test for the identification of antibodies against simian virus 40 in human serum and other fluids |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ITFE2009A000010A IT1399334B1 (it) | 2009-09-09 | 2009-09-09 | Test elisa indiretto per l'identificazione nel siero e in altri fluidi umani di anticorpi contro il virus sv40 mediante l'uso di peptidi sintetici specifici della sua regione precoce, codificante per l'oncoproteina antigene t grande |
Publications (2)
Publication Number | Publication Date |
---|---|
ITFE20090010A1 ITFE20090010A1 (it) | 2011-03-10 |
IT1399334B1 true IT1399334B1 (it) | 2013-04-16 |
Family
ID=41514976
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ITFE2009A000010A IT1399334B1 (it) | 2009-09-09 | 2009-09-09 | Test elisa indiretto per l'identificazione nel siero e in altri fluidi umani di anticorpi contro il virus sv40 mediante l'uso di peptidi sintetici specifici della sua regione precoce, codificante per l'oncoproteina antigene t grande |
Country Status (2)
Country | Link |
---|---|
IT (1) | IT1399334B1 (it) |
WO (1) | WO2011030300A1 (it) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2791162A2 (en) * | 2011-12-12 | 2014-10-22 | Janssen Diagnostics BVBA | Polyomavirus peptide sequences |
EP2938631B1 (en) | 2012-12-31 | 2018-12-19 | Neurimmune Holding AG | Recombinant human antibodies for therapy and prevention of polyomavirus-related diseases |
-
2009
- 2009-09-09 IT ITFE2009A000010A patent/IT1399334B1/it active
-
2010
- 2010-09-09 WO PCT/IB2010/054064 patent/WO2011030300A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
ITFE20090010A1 (it) | 2011-03-10 |
WO2011030300A1 (en) | 2011-03-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2487846T3 (es) | Anticuerpos anti-hepcindina y métodos de uso | |
BR112012003759A2 (pt) | "anticorpo anti-cmet e seu uso para a detecção e o diagnóstico de câncer." | |
CR20130621A (es) | Anticuerpos anti-angptl3 y usos de los mismos | |
CL2013003640A1 (es) | Proteina de union a il-17, construccion que comprende dicha proteina, un polipeptido ligador o un dominio constante de una inmunoglobulina; conjugado de dicha proteina; acido nucleico que la codifica; vector; celula huesped, metodo de produccion; composicion que la comprende; y su uso para reducir la actividad de la il-17 en una patologia en la cual il-17 es perjudicial (div.sol.2129-11). | |
CY2016023I2 (el) | Πρωτεϊνες συνδεσης αντιγονου προς προπρωτεϊνη κονβερτασης σουμπτιλισινης κεχιν τυπου 9 (pcsk9) | |
NI200800193A (es) | Anticuerpos humanos anti-il-23, composiciones, métodos y usos. | |
CL2013000843A1 (es) | Anticuerpo aislado o fragmento de union a antigeno del mismo que se une especificamente a cd48 humano y bloquea la interaccion entre cd48 humano y un receptor de cd48; composicion farmaceutica que lo comprende; y su uso. | |
BRPI0906478A2 (pt) | anticorpo anti-nr10 e uso do mesmo | |
BR112013029959A2 (pt) | uso de anticorpos anti-cgrp e fragmentos de anticorpo para prevenir ou inibir fotofobia ou aversão à luz em sujeitos em necessidade dos mesmos, especialmente os que sofrem de enxaqueca | |
CU23869B1 (es) | Anticuerpos anti-esclerostina y proteínas funcionales | |
SG10201510111PA (en) | Human monoclonal antibody with specificity for dengue virus serotype 1 e protein and uses thereof | |
ZA201000093B (en) | Detection of antigens carried by erythrocytes and of anti-erythrocyte antibodies | |
SMAP200800060A (it) | Anticorpi che legano la proteina umana tirosina fosfatasi beta (hptpbeta) e loro usi | |
BR112012019475A2 (pt) | "uso de um anticorpo monoclonal anti-cd 44 anticorpo anti-cd44 humanizado e kit para a detecção da presença de hnscc em uma amostra | |
EP1915176A4 (en) | ULTRASENSITIVE IMMUNOASSAY AND ANTIBODIES FOR DETECTION OF BLOOD FACTOR VIII | |
BR112014002140A2 (pt) | anticorpo anti-cxcr4 e uso do mesmo para a detecção e o diagnóstico de câncer | |
IL214779A (en) | Isolated monoclonal antibody or epitope-binding antibody on cadm1, methods of preparation and use for drug preparation | |
BRPI0806589A2 (pt) | Catalisador, sua preparação e uso. | |
BRPI0914782A2 (pt) | peptídeos de epítopos de cdca1 e vacinas contendo os mesmos | |
BRPI0821211A2 (pt) | Anticorpo anti-humano cd34 humanizado, o método de preparação e usos do mesmo. | |
IL202598A0 (en) | High sensitivity immunoassays and kits for the determination of peptides and proteins of biological interest | |
FI20075251A0 (fi) | Immunomääritys epästabiilien antigeenien määrittämiseksi | |
BR112012033163A2 (pt) | ''anticorpos monoclonais, linhagens celulares, usos de um anticorpo, kit, métodos para detectar um anticorpo, composição de anticorpo e uso de uma composição de anticorpo'' | |
CL2011002994A1 (es) | Construccion de proteina que comprende polipeptido casb7439; composicion inmunogenica que comprende dicha construccion; uso de la composicion porque sirve para inducir respuesta inmunitaria al casb7439 en un animal. | |
IT1399334B1 (it) | Test elisa indiretto per l'identificazione nel siero e in altri fluidi umani di anticorpi contro il virus sv40 mediante l'uso di peptidi sintetici specifici della sua regione precoce, codificante per l'oncoproteina antigene t grande |